Relief Therapeutics Holding AG (RLFTF)

[r_deckard]

Again a notice of delisting to BRPA:

As previously reported, on November 23, 2020, Big Rock Partners Acquisition Corp. (the “Company”) received notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, as of November 20, 2020, the Company was not in compliance with Nasdaq Listing Rule IM-5101-2 (the “Rule”), which requires a special purpose acquisition company to complete one or more business combinations within 36 months of the effectiveness of the registration statement filed in connection with its initial public offering. Since the Company’s registration statement became effective on November 20, 2017, it was required to complete an initial business combination by no later than November 20, 2020, and was therefore subject to delisting unless the Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company timely requested a hearing, which stayed any further delisting action by the Staff.

On January 4, 2021, the Company received a second notice from the Staff stating that the Company’s failure to hold an annual shareholder meeting for fiscal 2019 by December 31, 2020, as required by Nasdaq Listing Rule 5820, could serve as an additional basis for delisting. At the hearing, the Company will address both issues by presenting its plan to complete the previously announced proposed merger with NeuroRx, Inc. and thereby evidence compliance with all applicable criteria for initial listing on The Nasdaq Capital Market and request an extension of time to do so. The merger agreement previously filed, indicates among other requirements that there will be an election of the directors as part of the shareholder meeting to vote on the merger.

Although the Company is working with all due haste to complete the merger, there can be no assurance that the Panel will grant the Company’s request for continued listing pending the merger’s completion or that the Company will be able to complete the merger within the period of time that may be granted by the Panel. The Panel has the authority to grant the Company an extension through no later than May 24, 2021.

https://sec.report/Document/0001654954-21-000296/?_gl=1*b6mofh*_ga*dVFjcmpiczBMbGZUdUl0NXdpenRIWDNPSmJJY1g5WDBWMkNaU0NRM3BxRGlpcTc1NUpiOFY3S0YxWkNZaEE4RA&fbclid=IwAR2X9LiHbagbTjEWHTH6V0U4nbJEqkg36WEvay_LTgESHtq5XzRiIMcipk8